Clinical Trials Directory

Trials / Sponsors / Radius Pharmaceuticals, Inc.

Radius Pharmaceuticals, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Phase 32023-01-01
TerminatedA Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndr
Prader-Willi Syndrome
Phase 2 / Phase 32022-04-13
TerminatedA Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Particip
Prader-Willi Syndrome
Phase 22018-09-06
TerminatedA Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile
Infantile Spasm
Phase 32018-09-05
TerminatedCannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Phase 22018-05-09
TerminatedLong-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Tr
Childhood Absence Epilepsy
Phase 22018-02-20
TerminatedCannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
Childhood Absence Epilepsy
Phase 22017-12-29
TerminatedStudy to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor
Vasomotor Symptoms, Hot Flashes
Phase 22015-12-01
CompletedA Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women
Hot Flashes
Phase 22009-03-01